The International Master in Innovative Medicine (IMIM) is a two-year MSc program focused on translational biomedical research, aiming to train the next generation of leading scientists, entrepreneurs, and innovators. Jointly organized by four top universities (the University of Groningen, Heidelberg University, the University of Tartu, and Uppsala University), it equips students with the skills and knowledge to excel across disciplines, sectors, and countries, with access to extensive academic and industry networks.